19 September 2021>: Articles
Insulin-Induced Edema in a Patient with Type 2 Diabetes Mellitus
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Rare disease, Clinical situation which can not be reproduced for ethical reasons
Mohammed E. Elmahal A , Mahmoud M. Ramadan B*DOI: 10.12659/AJCR.931960
Am J Case Rep 2021; 22:e931960
Table 1. Results of laboratory investigations done for the patient on index admission.
Variable (unit) | Result | Reference range |
---|---|---|
Total leucocyte count (×10/mL) | 8.50 | 4.0–11.0 |
Hemoglobin (gm/dL) | 11.4 | 12.0–15.0 |
Platelet count (×10/mL) | 307 | 150–450 |
C-reactive protein (mg/L) | 13.0 | ≤7.50 |
Sodium (mmol/L) | 139 | 135–145 |
Potassium (mmol/L) | 3.7 | 3.6–5.10 |
Chloride (mmol/L) | 106 | 98–107 |
Calcium (mmol/L) | 2.26 | 2.10–2.60 |
Phosphorus (mmol/L) | 1.21 | 0.87–1.45 |
CO (mmol/L) | 21.5 | 23.0–29.0 |
Bicarbonate (mmol/L) | 28.5 | 22.0–32.0 |
Random glucose (mmol/L) | 12.3 | 4.0–7.8 |
Urea (mmol/L) | 5.0 | 2.0–7.1 |
Creatinine (μmol/L) | 66 | 53–97 |
Osmolality (mOsm/kg) | 276 | 275–295 |
Total protein (gm/L) | 72 | 61–79 |
Albumin (gm/L) | 30 | 35–52 |
Total bilirubin (μmol/L) | 12 | 5–21 |
Alanine aminotransferase (IU/L) | 27 | 14–54 |
Alkaline phosphatase (IU/L) | 74 | 42–98 |
Prothrombin time (s) | 12.7 | 10–14 |
Partial thromboplastin time (s) | 39 | 28–40 |
D-dimer (mg/L) | ≤2 | |
Brain-type natriuretic peptide (ng/L) | 79 | ≤99 |
Antinuclear antibody | Negative | Negative |
Anti-double stranded DNA antibodies (IU/mL) | ≤30.0 | |
Total cholesterol (mmol/L) | 3.87 | ≤5.18 |
Triglycerides (mmol/L) | 1.32 | ≤1.7 |
Low-density lipoprotein cholesterol (mmol/L) | 2.38 | ≤2.59 |
Thyroid stimulating hormone (mIU/L) | 8.3 | 0.27–4.20 |
Free T4 (pmol/L) | 12 | 12–22 |
Anti-thyroid peroxidase antibodies (kU/L) | 30 | ≤34 |
Cortisol level at 8 am (nmol/L) | 254 | 171–536 |
Urinary 24-hour albumin (mg) | 322 | ≤150 |